|
Jun 18
|
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions
|
|
May 23
|
ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?
|
|
May 23
|
Is it Worth Retaining ResMed Stock in Your Portfolio Now?
|
|
May 23
|
1 Surging Stock with Exciting Potential and 2 to Avoid
|
|
May 21
|
Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed
|
|
May 20
|
1 Unpopular Stock that Should Get More Attention and 2 to Brush Off
|
|
May 15
|
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
|
|
May 15
|
Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest
|
|
Apr 8
|
Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?
|
|
Apr 8
|
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)
|
|
Apr 3
|
ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US
|
|
Apr 3
|
ResMed Inc. (RMD): A Bull Case Theory
|
|
Apr 3
|
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
|
|
Apr 2
|
Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock
|
|
Apr 2
|
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
|
|
Mar 13
|
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic
|
|
Mar 12
|
NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus
|
|
Mar 12
|
RMD Stock Likely to Benefit From the New Brand Evolution Strategy
|
|
Mar 11
|
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
|
|
Mar 11
|
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
|